Global Markets for Research Antibodies

Report Code: BIO141D

Publish Date: Feb 2024

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for research antibodies is estimated to increase from $3.7 billion in 2023 to reach $5.8 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.

Report Includes

  • 145 data tables and 45 additional tables
  • An overview of the global market landscape related to the research antibodies
  • In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by product, clonality, application, major reactivities, host species, end-user, and geographical region
  • Discussion on the factors affecting the companies’ market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
  • Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
  • Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
  • Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry’s growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
  • Coverage of new discoveries in biological sciences, rapid technological developments in the IVD industry, new antibody technologies and antibody types, and assessment of antibody-based drug discovery and development
  • Discussion on advantages and disadvantages of antibody discovery technologies with examples of antibody production, and information on REpAb technology
  • Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
  • Examination of environmental, social, and corporate governance (ESG) developments, a relevant patent analysis; and merger and acquisitions (M&A), venture fundings, and emerging technologies in the global research antibodies
  • Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses, including Abcam Plc, Thermo Fisher Scientific Inc., Cell Signaling Technology Inc., Merck KGaA, Sino Biological Inc., and Bio-Rad

Report Scope

This study focuses on the market side of research antibodies, as opposed to the technical side. Different market segments for this specific market are covered. Application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC)(types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including recombinant antibodies; customer type-based market segments include universities and academic institutions, pharmaceutical and biotech companies and other types of customers (e.g., governmental research labs, contract research organizations [CROs]); geography-based market segments include North America, Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.

In this report, the market for research antibodies is segmented based on product type, clonality, host species, major reactivities, applications, end-user, and geography. Based on application type, the market is segmented into enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC) (i.e., types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC). Based on major reactivities, the market is segmented into anti-human, anti-rat and anti-mouse. The market is also presented based on product type, which is further segmented into primary and secondary antibodies.

The market has been geographically segmented into the North America, Europe, Asia-Pacific and Rest of the World (i.e., South America, Middle East and Africa) regions. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, and GCC countries) will be covered in the regional segment. For market estimates, data will be provided for 2022 as the base year, with estimates for 2023 and forecast value for 2028.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $3.5 billion
Market size forecast $5.8 billion
Growth rate CAGR of 9.2% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Type, Application, End user, Host Species, Major Reactivity, Clonality, Country, and Geographic Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia & New Zealand, Brazil, and GCC Countries
Key Market Drivers
  • New discoveries in biological sciences.
  • New antibody manufacturing technologies and new antibody types.
  • Antibody-based drug discovery and development.
  • Increased government funding, particularly in emerging markets.
Companies studied
JACKSON IMMUNORESEARCH INC.LONZA
CELL SIGNALING TECHNOLOGY INC.DANAHER CORP.
BIO-TECHNEBD
ABSOLUTE ANTIBODYAGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.THERMO FISHER SCIENTIFIC INC.
SINO BIOLOGICAL INC.ROCKLAND IMMUNOCHEMICALS INC.
SANTA CRUZ BIOTECHNOLOGY INC.MERCK KGAA
UNITED STATES BIOLOGICAL
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The market is projected to grow from $3.5 billion in 2022 to $5.8 billion in 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period.
The key factors driving the growth of the Global Market of Research Antibodies
  • Antibody-based drug discovery and development
  • New discoveries in biological sciences
  • New antibody manufacturing technologies and new antibody types
  • Developed and Increasing Research Areas.
The Global Market of Research Antibodies is segmented based on
  • Application
  • End user
  • Type
  • Host Species
  • Major Reactive
  • Clonality
  • Country
  • Region
By Application, western blotting and flow cytometry segment is anticipated to dominate the market by the end of 2028.
North America holds the highest market share in the market in terms of region.

Analyst Credentials

Partha Sarathi Das– Associate Consultant-Life Science Research
Partha Sarathi has an experience of nearly a decade in multiple domains, including healthcare, life science, biotechnology, pharmaceuticals, and healthcare IT. His expertise is in designing research studies, gathering data, and performing analysis, ultimately providing clients with actionable insights and recommendations based on their unique business needs. Designs proposal and participates in client queries for quick delivery based on their unique business needs. Academically, Parthasarathi holds a master’s degree in Biotechnology and a bachelor’s degree in Industrial Biotechnology.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Research Antibodies472Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market and Technology Background20Free
Chapter- 4: Research Antibodies 18Free
Chapter- 5: Market Dynamics10Free
Chapter- 6: Market Breakdown by Type of Antibody11Free
Chapter- 7: Market Breakdown by Clonality11Free
Chapter- 8: Market Breakdown by Major Reactivity13Free
Chapter- 9: Market Breakdown by Application28Free
Chapter- 10: Market Breakdown by Host Species19Free
Chapter- 11: Market Breakdown by End User11Free
Chapter- 12: Market Breakdown by Region235Free
Chapter- 13: Sustainability in the Research Antibodies Industry: An Environment, Social and Governance Sustainability in the Research 15Free
Chapter- 14: Emerging Technology for Antibody Discovery and Generation14Free
Chapter- 15: Approved Monoclonal Antibodies, 2018-20233Free
Chapter- 16: M&A and Venture Funding Outlook3Free
Chapter- 17: Competitive Landscape10Free
Chapter- 18: Company Profiles41Free
Chapter- 19: Appendix: Acronyms1Free
Published - Apr-2021| Analyst - BCC Publishing| Code - BIO141C

Report Highlights

The global market for research antibodies should grow from $2.7 billion in 2020 to $3.7 billion by 2025 with a compound annual growth rate (CAGR) of 6.5% for the period of 2020-2025.

Report Includes

  • 64 data tables and 25 additional tables
  • An overview of the global market for research antibodies
  • Estimation of the market size and analyses of global market trends, with data from 2018, 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Discussion on the factors affecting the companies’ market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
  • Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
  • Market share analysis of research antibodies based on product, clonality, application, end-user and region and evaluation of current market trends, market size and forecast
  • Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
  • Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry’s growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
  • Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players of the industry, including Merck KGaA, Thermo Fisher Scientific, United States Biological, Beckman Coulter Inc., Agilent Technologies Inc. and Cell Signaling Technology
Published - Jan-2018| Analyst - Mike (Ke Ke) Fan| Code - BIO141B

Report Highlights

The global market for research antibodies should reach $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8%, from 2017 to 2022.

Report Includes

  • 47 data tables and 3 additional table
  • An overview of the global market for antibodies used in research.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Segmentation of the market by regions, product types, research applications, species, and major research areas.
  • Details concerning end users, purchasing factors, new market trends, and potential growth opportunities that are available.
  • Discussion on the factors affecting strategies of antibody companies, the effect of research funding, and third-party quality evaluation systems.
  • Analysis of the competitive landscape and key competitors’ market shares.
  • Profiles of major companies: Abcam PLC, Abnova, Active Motif, Agilent Technologies, BD Biosciences, Beckman Coulter Inc., Bethyl Laboratories, BioLegend.
Published - Jan-2015| Analyst - Mike (Ke Ke) Fan| Code - BIO141A

Report Highlights

The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019.

Report Includes

  • An overview of the global market for antibodies used in research.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Segmentation of the market by geography, product types, research applications, species, and major research area.
  • Details concerning end user types, purchasing factors, new market trends, and potential growth opportunities that are available.
  • Discussion on the factors affecting strategies of antibody companies, the effect of research funding, and third-party quality evaluation systems.
  • Analysis of the competitive landscape and key competitor market shares.

Related Reports

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - Feb 2024 | Publisher - Partha Sarathi Das | Code - BIO079E

The global market for biological therapeutic drugs is expected to increase from $452.9 billion in 2023 to $823.4 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.7% during the forecast period of 2023-2028.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Sep 2021 | Publisher - BCC Publishing | Code - BIO021F

The global protein drugs market should reach $394.2 billion by 2026 from $265.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.

Immunohistochemistry (IHC): Global Markets to 2022

Published - Aug 2018 | Publisher - Vijay Laxmi | Code - BIO161A

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Research Antibodies
Sample Report